QNL
- Product code
- QNL
- Device name
- Medium-Term Adjunctive Predictive Cardiovascular Indicator
- Device class
- Class 2
- 21 CFR
- 21 CFR 870.2210
- Medical specialty
- Cardiovascular
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 3
- Summaries archived here
- 3 (direct download)
- 510(k) clearances (all years, FDA)
- 5 (all years; only the last 3 years are listed here)
FDA classification definition
The adjunctive predictive cardiovascular indicator is a prescription device that uses software algorithms to analyze cardiovascular vital signs and predict future cardiovascular status or events within a defined medium-term period. This device is intended for adjunctive use with other physical vital sign parameters and patient information and is not intended to independently direct therapy.
510(k) clearances, last 3 years (3)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K233253 | 2024-06-21 | Agilemd, Inc. | eCARTv5 Clinical Deterioration Suite (eCART) | |
| K233216 | 2024-01-13 | Clew Medical , Ltd. | CLEWICU System | |
| K230842 | 2023-10-25 | Implicity, Inc. | SignalHF (IM008) |
Official FDA classification page: QNL
Classification and pathway per current FDA publications. Data from openFDA (CC0).